Related by context. All words. (Click for frequent words.) 68 Bayer HealthCare Onyx Pharmaceuticals 67 Accelerated Partial Breast Irradiation 66 recurrent metastatic ovarian cancer 66 MAGE A3 ASCI 66 HepaMate 66 coronary stent merged 66 BRIM2 65 Xelox 65 5 fluorouracil leucovorin 65 hypofractionated 65 including eniluracil ADH 65 registrational Phase 64 PROMUS Element Stent 64 kidney urologic 64 DEEP AF 64 confirmatory clinical 64 GVAX ® 64 deCODE ProstateCancer TM 64 evaluating tivozanib 64 vinorelbine tartrate 64 Dural Sealant 64 tumor angiogenesis inhibitors 64 PI3K/Akt pathway inhibitor 64 recombinant PSMA vaccine 64 fosbretabulin 64 GEM OS2 63 evaluating satraplatin 63 Panzem R NCD 63 biliary tract cancer 63 Stereotactic Body Radiation Therapy 63 FOLFOX6 chemotherapy regimen 63 deCODE AF TM 63 paclitaxel poliglumex 63 benign prostatic hyperplasia enlarged 63 accumulate preferentially 63 intra arterial chemotherapy 63 demonstrated clinically meaningful 63 VANTAS ® 63 EndoTAGTM 1 63 Stabilimax NZ 63 Vaxfectin TM 63 MelaFind R 63 BrachySil TM 63 EOquin TM 63 resectable pancreatic cancer 63 metastatic colorectal 63 noninvasive outpatient 63 potent suppressor 63 CINQUIL 63 FFR measurements 63 PSMA ADC 63 radiation chemoradiation 63 Scintigraphy 63 prospectively stratified 62 Anti Bacterial Envelope 62 deCODE BreastCancer 62 Phase #b/#a clinical 62 Crofelemer budesonide foam 62 acyclovir Lauriad R 62 YONDELIS 62 concurrent chemoradiation 62 anastrazole 62 recurrent malignant glioma 62 PrevOnco ™ 62 galiximab 62 Quinamed 62 catheter occlusion 62 OncoGel 62 antiangiogenic agent 62 via intradermal injections 62 neratinib 62 recurrent metastatic 62 FDG-PET/CT 62 GAMMAGARD 62 cardiac perfusion 62 HuMax EGFr 62 HGS ETR1 mapatumumab 62 chemosaturation 62 Solazed 62 pain palliation 62 microRNA profiling 62 BEZ# 62 Thiarabine 62 Degarelix 62 OnControl 62 VATS lobectomy 62 successfully commercialize Iluvien 62 NAVISTAR R 62 HDL Selective Delipidation 62 3D conformal radiation 62 Long Lesion 61 balloon brachytherapy 61 mertansine 61 PEGylated interferon 61 HGS# 61 Sipuleucel T 61 lung pancreatic 61 transarterial 61 Rheos System 61 eBx 61 pertuzumab 61 Allovectin 7 61 Myocardial Perfusion Imaging 61 SoftScan ® 61 rxRNA 61 novel emulsion formulation 61 Volumetric Modulated Arc 61 randomized controlled multicenter 61 visit www.genenews.com 61 balloon expandable stent 61 Curaxin CBLC# 61 Phase IIb III 61 Curaxin 61 PD LID 61 Biolimus A9 61 EGFr expressing metastatic colorectal 61 Exelixis compounds 61 Novolimus 61 Trofex 61 sapacitabine CYC# 61 demonstrated antitumor activity 61 VBLOC TM 61 targeted antifolate 61 humanised antibody 61 optical biosensors 61 introduced NEUGENE 61 involves threading 61 fusion enhancers 61 vein ablation 61 candidate CRLX# 61 LHRH receptor positive 61 AFRS TM 61 unresectable liver cancer 61 chemotherapy docetaxel 61 omega interferon 61 Aplidin 61 Vasomedical enhanced 61 orally inhaled migraine 61 Mammosite 61 raloxifene Evista 61 REVIVE Diabetes 61 targeted radiotherapeutic 61 CIPN 61 var arrContent = 61 PET tracers 61 Perforomist ™ Inhalation Solution 61 AKT inhibitor 61 urethral bulking agent 61 PORxin TM platforms 61 interstitial brachytherapy 61 ThermoDox R 61 OvaRex R 61 Cardio3KG 61 Diamondback #deg 61 farletuzumab 60 ALA PDT 60 hypoxia activated prodrug 60 oral dnaJP1 60 metastatic pancreatic 60 oral picoplatin 60 lenalidomide Revlimid R 60 chemoradiation therapy 60 Phase Ib II 60 Oral NKTR 60 MGN# 60 alvespimycin 60 Levulan ® PDT 60 Phase 1b clinical trials 60 Kahalalide F 60 Surgical resection 60 novel VDA molecule 60 helical TomoTherapy 60 personalized cellular immunotherapy 60 Zemplar Capsules 60 EchoCRT 60 var arrUrl = 60 NeuroSTAT ® 60 proprietary bioresorbable polymer 60 guaiac 60 untreated metastatic melanoma 60 pyrimidine nucleoside analog 60 recurrent glioblastoma multiforme 60 docetaxel Taxotere ® 60 GVAX Pancreas Vaccine 60 Allovectin 7 ® 60 NeuroMove TM 60 var arrMeta = 60 CHAMPION PCI 60 Hepatocellular Carcinoma HCC 60 bifurcation stent 60 OvaRex MAb 60 automated radiopharmaceutical distribution 60 vidofludimus 60 WallFlex Biliary RX 60 BR.# 60 dimebon latrepirdine 60 ImmunoBody ® 60 Balloon sinuplasty 60 cleavable linker 60 Xcellerated T Cells 60 ImmuKnow R 60 CIMZIA ™ 60 VisuMax 60 LEAPS TM 60 oncolytic virus therapies 60 preclinical efficacy 60 Locked Nucleic Acid LNA 60 PrevOnco 60 number NCT# ClinicalTrials.gov 60 prospective multicenter 60 Evoltra ® 60 phase IIb study 60 metastatic neuroendocrine tumors 60 Calmare pain 60 delta opioid receptor 60 HuMax 60 randomized discontinuation 60 SUTENT ® 60 metastatic malignant 60 multicenter Phase II 60 chemistry microbiology immunology 60 Proellex TM 60 prospective multicenter randomized 60 Signal X6 60 Zalypsis 60 ChronVac C R 60 transcranial Doppler ultrasound 60 postoperative chemotherapy 60 cytokine refractory 60 IMiDs ® 60 candidate TNFerade biologic 60 #mg ATC 60 imexon 60 PresbyLens ® 60 clot retrieval 60 coronary computed tomography 60 Altera Nebulizer System 60 differentiate squamous 60 thetreatment 60 Fleximer R 59 AE# vaccine 59 multicenter randomized controlled 59 IMA# 59 delivery polymer matrix 59 INS# [001] 59 gynecologic procedures 59 CLARITY study 59 Tarceva TM 59 unresectable tumors 59 Panzem R 59 Interferon beta 59 Trobalt 59 Enhanze Technology 59 intensity modulated 59 chimeric monoclonal antibody 59 radiochemotherapy 59 manufactures minimally invasive 59 trastuzumab DM1 T DM1 59 liposomal formulation 59 MGuard ™ 59 Gliadel Wafer 59 tubulin inhibitor 59 PC Detect SM 59 Microwave Ablation System 59 Microfocus APA 59 Coronary angiography 59 Anticalins R 59 Aeolus Pharmaceuticals Announces 59 ® SPECT imaging 59 intracavitary 59 generation purine nucleoside 59 Requires 4G 59 somatostatin analog 59 external counterpulsation systems 59 evaluating mipomersen 59 lymphatic mapping 59 rALLy 59 Intensity Modulated 59 NeuroFlo 59 BRIM3 59 Vitaxin 59 HDR brachytherapy 59 Curon Control 59 MiStent DES 59 antiangiogenic therapy 59 Pemetrexed 59 ospemifene 59 Fine needle aspiration 59 oral rivaroxaban 59 CellOptics platform 59 hypervascular tumors 59 biologic antibody 59 Aflibercept 59 EFAPROXYN 59 dimensional conformal radiotherapy 59 VersaFilm 59 Vascugel 59 develop HBV reactivation 59 oncology radiation oncology 59 sd rxRNA 59 Bendamustine 59 Virulizin ® 59 forodesine 59 Lumbar Interbody Fusion 59 tolerability pharmacokinetics 59 myocardial revascularization 59 RX ACCULINK 59 Trastuzumab DM1 59 Stereotactic body 59 transfemoral 59 assessing T DM1 59 systemic immunosuppressive drugs 59 recurrent NSCLC 59 ChromoCure develops 59 CARE HF 59 vivo preclinical 59 Hyperbaric Oxygen Therapy HBOT 59 USHE groundbreaking pocket BLU 59 Chemoradiation 59 bioengineered tissue 59 REMINYL ® 59 cardiac resynchronisation therapy 59 CBLC# 59 oral levofloxacin 59 blinded randomized placebo controlled 59 Orazol 59 intradermal injections 59 NPM1 mutation 59 CURE AF 59 adjuvant colon cancer 59 ER CHOP 59 radiotherapy RT 59 budesonide MMX Phase III 59 trans urethral resection 59 refractory colorectal cancer 59 visit www.rtanswers.org 59 Temsirolimus 59 tolevamer 59 WavSTAT 59 budesonide foam 59 HALO# [002] 59 treat chronic sinusitis 59 TransVax 59 pipeline ImmunoGen collaborators 59 evaluating Actimmune 59 HuMax TAC 59 Ophena 59 basal bolus regimen 59 miconazole Lauriad ® 59 Phase Ib IIa 59 controlled analgesia PCA 59 generation nucleoside analog 59 BladderChek 59 AAG geldanamycin analog 59 sargramostim 59 dimensional conformal radiation 59 Cloretazine ® 59 Augment Injectable 59 Motesanib 59 neuronal nicotinic receptor NNR 59 Safinamide 59 Secca System 59 HuMax CD#b 59 PhG alpha 1 58 volumetric modulated arc 58 Optical Coherence Tomography 58 AGILECT R 58 ablative therapy 58 TLIF 58 radiolabeled TM# 58 Deforolimus 58 chemoradiotherapy 58 genomic profiling 58 TransVax ™ 58 NanoStat 58 aldehyde dehydrogenase ALDH2 deficiency 58 acyclovir Lauriad ® 58 proton MR spectroscopy 58 INTEGRILIN R eptifibatide Injection 58 volociximab 58 neo adjuvant 58 OSI Tarceva 58 Fibrin MB 58 intraoperative radiotherapy 58 Diabetic Foot Ulcer 58 OncoVEX GM CSF 58 humanised monoclonal antibody 58 ELACYT 58 SELDI TOF MS 58 POTELLIGENT ® Technology 58 double blinded randomized 58 bisulfite sequencing 58 Pertuzumab 58 TransVax tm 58 DCVax ® Brain 58 Oncotype 58 non nucleoside 58 Ellex 2RT 58 phase IIb clinical 58 treating neuropathic pain 58 ALSYMPCA 58 PRESEPT study 58 Anavex #-# 58 radiofrequency ablation RFA 58 iliac artery disease 58 LB# [003] 58 bevacizumab Avastin ® 58 CCX# B 58 transarterial chemoembolization 58 NovoTTF 58 Bezielle 58 Potelligent TM 58 RhuDex R 58 opioid naive 58 Alfacell proprietary ribonuclease 58 trial evaluating PRX# 58 eTag assays 58 TAXUS ATLAS 58 ZOLINZA 58 pharmacodynamic properties 58 HuMax Wnt 58 ERBITUX Cetuximab 58 HeartNet 58 Skinvisible receives 58 eribulin mesylate 58 Decitabine 58 immunotherapeutic agent 58 SpyGlass System 58 EUS FNA 58 directed thrombolysis 58 bavituximab monotherapy trial 58 Proxinium TM 58 Warfarin Coumadin 58 Electronic Brachytherapy 58 INxin TM 58 dirucotide MBP# 58 thoracoscopic lobectomy 58 rotary VAD 58 transcranial magnetic stimulation TMS 58 Aplidin R 58 surgical resection cavity 58 punctal plug delivery 58 docetaxel Taxotere R 58 AF Suppression 58 vitro dissolution 58 Computed tomography CT 58 pharmacokinetic characteristics 58 Empatic ™ 58 clevidipine 58 transabdominal 58 CellSearch ™ 58 pacemaker manufacturer Intrapace 58 chromosomal mutations 58 taxane derivative 58 basal insulin analogue 58 antibody MAb 58 computed tomographic 58 Clinical Antipsychotic Trials 58 BRAF inhibitor 58 clinical trials Archexin 58 stereotactic radiotherapy 58 PET CT scanning 58 PROMUS TM 58 CRLX# 58 chemo immunotherapy 58 novel oral anticoagulant 58 PERSEUS 58 Prospective Randomized 58 PRIMO CABG 58 maximally tolerated dose 58 VESTASYNC II trial 58 Oxaliplatin 58 RhuDex ® 58 Corus CAD 58 histone deacetylase inhibitor 58 hPTH #-# 58 Intra arterial 58 respiratory gating 58 management biostatistical analysis 58 NSCLC tumors 58 everolimus eluting stents 58 HALO# [001] 58 deforolimus 58 haematologic 58 paclitaxel carboplatin 58 CA9 SCAN 58 Neuradiab 58 European Sepsis Trial 58 Dr. Cassian Yee 58 tramiprosate Alzhemed TM 58 oral deforolimus 58 multicenter Phase III 58 gemcitabine chemotherapy 58 Pivotal Phase 58 EP #R 58 TUMT 58 Dr. Gabriel Lasala 58 near infrared spectroscopic 58 IMPACT DCM 58 concurrent ITP 58 acadesine 58 developed preclinically 58 Cardiac ablation 58 next generation URAT1 58 Stereotactic radiosurgery 58 QuadraSphere 58 ENMD # 58 ADVEXIN clinical 58 Fc gamma receptor 58 TM Embolic Protection 58 cetrorelix pamoate 58 CVac 58 GRN# 58 needle electromyography procedures 58 STARFlex R 58 depsipeptide 58 intensity modulated radiotherapy IMRT 58 nonrandomized 58 multimodality imaging 58 peritoneal carcinomatosis 58 HydroFix 58 adjunctively 58 TTF therapy 58 #I TM# 58 GeneSightRx 58 transurethral 58 RecoveryRx TM 58 chemotherapy cisplatin 58 Tarvacin Anti Cancer 58 Omacetaxine 58 LEVADEX TM 58 hereditary deficiency 58 ToGA 58 HGS ETR2 58 riociguat 58 Transcranial Magnetic Stimulation TMS 58 EDEMA3 trial 58 Lixivaptan 58 MyoCell SDF 1 58 albiglutide 58 docetaxel chemotherapy 58 #Gy 58 Phase Ib clinical trials 58 relapsing remitting MS RRMS 58 Initiated Phase 58 Immunotherapeutic 58 BrachySil 58 stereotactic radiation 58 V3D Colon 58 Vaxfectin ® 58 paclitaxel eluting stents 58 delipidation 57 ALN VSP Phase 57 Phase 1a clinical 57 Irinotecan 57 NEUVENGE 57 Matrix Phase 2b 57 Elagolix 57 Optical coherence tomography 57 ADMIRE HF 57 Talotrexin 57 AeroLEF TM 57 TELINTRA R 57 com BlackSingles.com R 57 XL# SAR# 57 therapeutic radiopharmaceuticals 57 endoscopic resection 57 PORxin TM 57 Annamycin 57 please visit www.advaxis.com 57 AVONEX PEN 57 sirtuin modulators 57 DEB# 57 Elizee suffered 57 stage hypoxia activated 57 EDEMA3 57 Captisol ® 57 QTinno TM 57 symptomatic paroxysmal AF 57 subconjunctival injection 57 Pivotal Trial 57 tumor excision 57 Edge STudy 57 VNP#M 57 metastatic gastric 57 selective orally bioavailable 57 Iluvien TM 57 EHT AGN 57 mg administered orally 57 CorVue ™ 57 randomized controlled Phase 57 sonographically guided 57 autologous cellular immunotherapy 57 DiLA2 Platform 57 PF # [002] 57 electrochemical detection 57 transesophageal echocardiography 57 reslizumab 57 carbohydrate polymers 57 either acutely decompensated 57 inhibits angiogenesis 57 resorbable biomaterials 57 proprietary PEGylation 57 SinuNase ™ 57 pelvic malignancies 57 proprietary encapsulation 57 noninvasive imaging 57 cortical stimulation 57 bortezomib Velcade 57 COR Analyzer 57 microwell plate 57 Edwards SAPIEN valve 57 RECORD1 57 phase Ib 57 TLR agonists 57 NSABP C 57 MVA MUC1 IL2 57 indibulin 57 EEG abnormalities 57 vaccine ChronVac C 57 ganaxolone 57 dose escalation clinical 57 GLP1 agonist 57 antiretroviral naïve 57 Phase Ib clinical 57 flavopiridol 57 produces radioisotopes 57 human IgG1 monoclonal 57 Rigel R# 57 liver resection surgeries 57 thorough QT 57 PRIMO CABG2 57 autologous chondrocyte implantation 57 oral prodrug 57 samalizumab 57 florbetaben 57 microsphere therapy 57 cardioverter defibrillator 57 dose escalation phase 57 Teriflunomide 57 IONSYS TM 57 NADiA 57 Zolpimist ™ 57 pediatric malignancies 57 Optical Biopsy System 57 ABSORB clinical 57 Lewy bodies DLB 57 Perforomist TM formoterol fumarate 57 ADVEXIN therapy 57 sputum cytology 57 insulin parathyroid hormone 57 ocular formulation 57 NSABP B 57 HepDirect prodrug 57 intravenous drip dangling 57 RAV# 57 Attrius TM PET 57 ZYBRESTAT fosbretabulin 57 Endotoxin Activity Assay 57 DXL TM 57 novel peptide 57 Coronary stents 57 MALDI-TOF/TOF 57 Phase #b/#a trial 57 Allovectin 7 R 57 VeraTag 57 Evalve MitraClip R 57 x ray angiography 57 Solorel TM 57 radiation therapy IMRT 57 ALN TTR# 57 IOP lowering 57 Pivotal Phase III 57 ORENCIA R 57 Vaxfectin R 57 CustomVue 57 RhuDex TM 57 hematological relapse 57 Glatiramer acetate 57 neoadjuvant treatment 57 lumbar spine fusion 57 Embolic Protection Device 57 CyPath ® 57 Intraoperative Radiation Therapy IORT 57 TriGrid 57 concomitant cardiac 57 Rigorous scientific 57 Stereotaxis System 57 IIa clinical trials 57 SEPET TM 57 presbyopia correcting 57 AQUA ® 57 multicenter randomized placebo controlled 57 Oxiplex 57 REGEN trial 57 ACTCellerate 57 topical hemostat 57 mild hepatic impairment 57 SNT MC# 57 Resolute stent 57 DCE MRI 57 Radical prostatectomy 57 Pharmacokinetic parameters 57 transcutaneous immunization TCI 57 Neuvenge 57 neurologic progression 57 statistically significant efficacy 57 cilengitide 57 epicardial ablation 57 CryoPlasty 57 Ceragenin ™ 57 chemotherapeutic regimen 57 Ovonic fuel 57 MelaFind ® 57 CURRENT OASIS 7 57 SCIB1 57 noninvasive painless 57 nonfusion 57 immunochemical 57 skeletal sarcomere activators 57 evaluating satraplatin plus 57 trastuzumab Herceptin ® 57 pegylated liposomal doxorubicin 57 MIRAPEX ER 57 rALLy clinical trial 57 Apoptone HE# 57 EXPLORE Xa 57 placebo controlled dose escalation 57 mean ± SEM 57 opto acoustic 57 Intravascular 57 placebo controlled multicenter 57 non topical formulations 57 miRNA biomarkers 57 HepaMate ™ 57 Hexvix ® 57 Testosterone MDTS ® 57 intravenous cyclophosphamide 57 huN# DM1 57 Tasigna prolongs 57 TTF Therapy 57 Biophan patent 57 CaPSURE 57 Zevalin consolidation 57 Erimos 57 NP2 57 TargetScan 57 beta Estradiol 57 refractory prostate cancer 57 JAK2 inhibitor 57 ESPRIT therapy 57 eligen 57 Fingolimod 57 RhuDex 57 use transdermal sumatriptan 57 targeting CD# 57 Randomized controlled 57 PharmFilm 57 INCB# [001] 57 randomized Phase IIb 57 fight PI3K activation 57 Comparative Genomic Hybridization 57 FIRMAGON 57 stent coating 57 Kamada AAT 57 preoperative staging 57 pharmacodynamic PD 57 Cardica Microcutter XPRESS 57 InN 57 Dr. Assa Amit 57 EECP R 57 cervical prostate 57 Anturol TM 57 NuroPro PD 57 antitumor effect 57 SUCCEED trial 57 Enhanced External Counterpulsation 57 HGS ETR1 57 quantitative gene expression 57 ABSORB trial 57 GeneICE 57 phase IIa clinical 57 NPC 1C 57 THR beta agonist 57 SAVI applicator 57 proprietary intranasal insulin 57 Daclizumab 57 bronchoscopic procedure 57 transrenal DNA 57 radionuclide imaging 57 ENESTnd 57 Ultrasound imaging 57 multitargeted 57 TAXUS Liberte Stent 57 systemic RNAi therapeutic 57 www.varian.com 57 inhaled treprostinil 57 Coronary CTA 57 photocoagulation 57 Umbilical cord stem cells 56 Fluorescence microscopy 56 Prodarsan R 56 Intervention Effectiveness 56 initiate multicenter 56 repetitive transcranial magnetic stimulation 56 epoetin alpha 56 inhaled iloprost 56 OMP #M# 56 Teriparatide 56 oral Janus kinase 56 MiniArc Precise 56 dosimetric 56 LHRH antagonist 56 THERMOCOOL R 56 nomograms 56 NMR LipoProfile test 56 cerebral oximetry 56 blood clot dissolver 56 treatment naive genotype 56 Arikace 56 Panzem 56 DAPT 56 Zone Sonography TM 56 iobenguane 56 Elekta Axesse 56 dacarbazine chemotherapy 56 AS# amonafide L malate 56 proteomics bioinformatics 56 multicentre randomized controlled 56 Solulin 56 bronchoscopic 56 Syndication Desk 56 computer tomography CT 56 RE MODEL 56 APTIVUS R 56 trials RCTs 56 CELVAPAN H#N# 56 BrachySil ™ 56 cartilage regeneration 56 eFlow ® 56 TROPOS 56 TEMSO 56 self expanding nitinol 56 Anti VEGF 56 BEXXAR Therapeutic Regimen 56 LymphoStat B TM 56 novel therapeutic antibodies 56 PROLARIS 56 electrochemical sensor 56 GERD migraine headaches 56 vemurafenib 56 Extracorporeal Shock Wave 56 gauge vitrectomy 56 CCR9 antagonist 56 metastatic liver 56 morphometric vertebral fractures 56 OMS# 56 Adnectin 56 ClearPath HDR 56 Gentamicin Surgical Implant 56 mTOR inhibition 56 craniomaxillofacial 56 SPECT CT imaging 56 Cystoscopy 56 QOPI 56 UltiMAb TM 56 Neuromodulation System 56 trastuzumab emtansine T DM1 56 SERCA2a 56 OMEGA Stent 56 cellular immunotherapy 56 buccal delivery 56 Raptiva r 56 novel histone deacetylase 56 catheter ablations 56 CALGB # [002] 56 constipation OIC 56 DASISION 56 AAIsafeR 56 prospective randomized multicenter 56 immunotherapeutic vaccine 56 medically inoperable 56 Primary endpoints 56 pluripotent embryonic 56 Tesetaxel 56 ongoing Phase IIIb 56 Lofexidine 56 angiogenesis inhibitor 56 HDL Mimetic Peptide 56 cediranib 56 MKC# MKC# PP 56 BY DAVID CRIGGER 56 IMC #B 56 perfusion imaging 56 ALN HTT 56 ophthalmoscopy 56 choroidal vasculopathy 56 BioMatrix 56 Modrenal 56 phosphatidylserine PS targeting 56 repair TEVAR 56 ESBA# 56 Non inferiority 56 pulsed Doppler 56 Urocortin 2 56 CINTREDEKIN BESUDOTOX 56 transvaginal sonography 56 CATIE AD 56 LBH# 56 Phase III Clinical Trial 56 proprietary biomaterials 56 inhaled AAT 56 INTRABEAM 56 bone marrow aspiration 56 e2 Collector 56 Randomized Phase 56 Gleevec resistant 56 OnDose TM 56 GRNCM1 56 immunohistochemical 56 Vimpat R 56 ARB telmisartan 56 SPIRIT FIRST 56 Nerve Stimulation 56 Pivotal Clinical Trial 56 RIGScan R 56 phase IIIb 56 Carotid endarterectomy 56 Interactive Orthopedic 56 purine analog 56 Neo Bladder Augment 56 Tykerb lapatinib 56 kinase profiling 56 disc arthroplasty 56 VANTAS R 56 enhanced external counterpulsation 56 Val HeFT 56 EC Cysteamine 56 Cellulaze 56 ARRY # 56 VITAL Trial 56 nucleoside analog 56 oral ridaforolimus 56 Kathy Giusti myeloma 56 transthoracic 56 Fc fusion protein 56 Combidex 56 APEX PD 56 electrophysiologic 56 proven proprietary AcuForm 56 Silodosin 56 IL# PE#QQR 56 STEDESA 56 Direct Visualization 56 entinostat 56 pivotal bioequivalence 56 chemoembolization 56 multicentric 56 Patient Charting 56 Stretta System 56 HIFU therapy 56 DermaVir Patch 56 endoscopic autofluorescence imaging 56 commercialize ZYFLO CR 56 MiCK assay 56 nucleotide analogue 56 Adjunctive 56 xenograft models 56 Cariprazine 56 intensity modulated radiotherapy 56 bioresorbable stent 56 RF ablation 56 receptor tyrosine kinase inhibitor 56 bone grafting procedures 56 myoblast therapy 56 Ostabolin C TM 56 multislice 56 Endeavor drug eluting 56 Cardiopulmonary bypass 56 Vertebral Compression Fracture 56 pharmacodynamic parameters 56 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 56 HCD# [002] 56 RapidArc treatments 56 Initiate Phase 56 Dual Wavelength 56 recurrent ovarian 56 disposable catheter 56 Archexin 56 CardioFit 56 Endoscopic ultrasound 56 Epothilones 56 ongoing Phase 1b 56 induced tumor regression 56 masked placebo controlled 56 RE LY ® 56 Activated Collagen 56 candidate Trofex TM 56 ALTROPANE